Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas in the United States: Similarities and Differences

Authors

Jennifer Ng1, Jennifer Wu2,*
1Department of Medicine, New York University Langone Medical Center, United State
2Division of Hematology and Medical Oncology, New York University Cancer Institute, [email protected], United State
*Corresponding Author: Division of Hematology and Medical Oncology, New York University Cancer Institute, NY 10016, [email protected], United State. Tel: +1- 2122636485. Email: [email protected]

Hepatitis Monthly:Vol. 12, issue 10; 7635
Published online:Oct 25, 2012
Article type:Review Article
Received:May 09, 2012
Accepted:Aug 25, 2012
How to Cite:Ng J, Wu J. Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas in the United States: Similarities and Differences. Hepat Mon. 2012;12(10):7635. doi: https://doi.org/10.5812/hepatmon.7635

Abstract

Context:

Hepatitis B and Hepatitis C (HBV and HCV) infections are both major causes of hepatocellular carcinoma (HCC). However, HCC caused by each of these two viruses has unique characteristics that should be studied independently to that of another one. While HBV- and HCV-related HCCs share similar host and environmental risk factors such as male gender, age above 50 years old, family history of HCC, cirrhosis, obesity, and concomitant alcohol/tobacco use, they differ in their viral risk factors.

Evidence Acquisition:

The actual level of HBV DNA, the presence of HBV e antigen (HBeAg), and mutations in the viral genome are important predisposing factors to HCC development in HBV, whereas in HCV, viremia of any amount denotes an elevated risk. HBV and HCV also differ in their mechanisms of carcinogenesis. For example, HBV can integrate into the host genome and induce many different genetic alterations/mutations. Ultimately, though, both viruses act on similar pathways to produce HCC.

Result:

HBV and HCV are often transmitted differently - vertically (HBV) and horizontally (HCV), which may play a role in their distinct clinical presentations: HBV patients are younger and more frequently have larger/ bilobar tumors as opposed to HCV patients, who have worse liver function on diagnosis of HCC. Even the way they respond to treatment seems to be different. HBV-related HCC patients tend to progress faster after sorafenib treatments.

Conclusions:

Future studies should investigate the ways in which these differences between HBV- and HCV-related HCC can translate into more tailored treatment strategies for each etiology of HCC in order to improve outcomes of both.

Full Text

Full text is available in PDF

Copyright

© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

17
Feb
2014

The Effect of HBV Genotype C on the Development of HCC Differs Between Wild-Type Viruses and Those With BCP Double Mutations (T1762A1764)

Qin-Yan Chen,
Tim J Harrison,
Caroline A Sabin,
Guo-Jian Li,
Gao-Ming Huang,
Jin-Ye Yang
,et al.

Chen Q, Harrison TJ, Sabin CA, Li G, Huang G, et al. The Effect of HBV Genotype C on the Development of HCC Differs Between Wild-Type Viruses and Those With BCP Double Mutations (T1762A1764). Hepat Mon. 2014;14(2):e16214. doi: https://doi.org/10.5812/hepatmon.16214

31
Dec
2006

Molecular Aspects of Hepatocellular Carcinoma Caused by Hepatitis C Virus

Ali Karami,
Seyed Moayed Alavian,
Ali Najafi,
Mohammad Javad Hosseini

Karami A, Alavian S, Najafi A, Hosseini M. Molecular Aspects of Hepatocellular Carcinoma Caused by Hepatitis C Virus. Hepat Mon. 2006;6(2):. doi:

30
Oct
2012

Viral Hepatitis Induces Hepatocellular Cancer: What Can We Learn from Epidemiology Comparing Iran and Worldwide Findings?

Elisabeth Smolle,
Evelyn Zhrer,
Kira Bettermann,
Johannes Haybaeck

Smolle E, Zhrer E, Bettermann K, Haybaeck J. Viral Hepatitis Induces Hepatocellular Cancer: What Can We Learn from Epidemiology Comparing Iran and Worldwide Findings?. Hepat Mon. 2012;12(10):7879. doi: https://doi.org/10.5812/hepatmon.7879

19
Jan
2014

Comparative Proteomics of Sera From HCC Patients With Different Origins

Jamal Sarvari,
Zahra Mojtahedi,
Yasuhiro Kuramitsu,
Mohammad Reza Fattahi,
Abbas Ghaderi,
Kazuyuki Nakamura
,et al.

Sarvari J, Mojtahedi Z, Kuramitsu Y, Fattahi MR, Ghaderi A, et al. Comparative Proteomics of Sera From HCC Patients With Different Origins. Hepat Mon. 2014;14(1):e13103. doi: https://doi.org/10.5812/hepatmon.13103

24
Oct
2012

Epidemiological Pattern of Hepatitis B and Hepatitis C as Etiological Agents for Hepatocellular Carcinoma in Iran and Worldwide

Ahmed Zidan,
Hubert Scheuerlein,
Silke Schle,
Utz Settmacher,
Falk Rauchfuss

Zidan A, Scheuerlein H, Schle S, Settmacher U, Rauchfuss F. Epidemiological Pattern of Hepatitis B and Hepatitis C as Etiological Agents for Hepatocellular Carcinoma in Iran and Worldwide. Hepat Mon. 2012;12(10):6894. doi: https://doi.org/10.5812/hepatmon.6894

More by these authors

Jennifer NgPubMedScholar
Jennifer WuPubMedScholar
Share
Cited by
Metrics